Exelixis Inc (NAS:EXEL)
$ 36.115 0.265 (0.74%) Market Cap: 10.31 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.15 PB Ratio: 4.54 GF Score: 91/100

Q1 2020 Exelixis Inc Earnings Call Transcript

May 05, 2020 / 09:00PM GMT
Release Date Price: $25.29 (-1.33%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Exelixis First Quarter 2020 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to hand the conference over to your host, Ms. Susan Hubbard, EVP of Public Affairs and Investor Relations. Please proceed.

Susan T. Hubbard
Exelixis, Inc. - EVP of Public Affairs & IR

Thank you, Nita, and thank you all for joining us for the Exelixis First Quarter 2020 Financial Results Conference Call.

Joining me on today's call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; P.J. Haley, our Executive Vice President of Commercial; and Gisela Schwab, our Chief Medical Officer, who, together, will review our corporate, financial, commercial and development progress for the first quarter 2020 ended March 31, 2020. Peter Lamb, our Chief Scientific Officer, is also with us and will be joining for the Q&A session following our prepared remarks.

During the call today, we will refer to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot